Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients

(2013) Maria Grazia Castagna et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up

(2013) Eleonora Molinaro et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan-Kettering Cancer Center Risk Group Stratification

(2013) Iain J. Nixon et al.   THYROID

Combination of Initial Stimulation Thyroglobulins and Staging System by Revised ATA Guidelines Can Elaborately Discriminate Prognosis of Patients With Differentiated Thyroid Carcinoma After High-Dose Remnant Ablation

(2012) Min-Hee Kim et al.   CLINICAL NUCLEAR MEDICINE

Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients

(2012) Claire Schvartz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

(2012) Martin Schlumberger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

(2012) Ujjal Mallick et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin–Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid Cancer

(2010) Carole Spencer et al.   THYROID

Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis

(2009) Anna M. Sawka et al.   THYROID

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective

(2009) Paul Mernagh et al.   VALUE IN HEALTH

An Updated Systematic Review and Commentary Examining the Effectiveness of Radioactive Iodine Remnant Ablation in Well-Differentiated Thyroid Cancer

(2008) Anna M. Sawka et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA